August 12th 2024, 1:00pm
By Betty Geltz
When I noticed a lump in my breast, I immediately knew what it would be, so I worked to advocate for myself.
August 11th 2024, 3:00pm
By Charles Elwert
Even though my wife became quadriplegic after her breast cancer progressed, our insurance still did not help us out, so I became her caregiver full-time.
August 10th 2024, 6:00pm
By Ashley Chan
Walking up and down the street a few times a day can help prevent patients with kidney or bladder cancers from becoming deconditioned.
August 10th 2024, 2:00pm
By Chester Freeman
During chemotherapy for my chronic lymphocytic leukemia, I try my best to appreciate the positive aspects of life, like flowers and friends.
August 9th 2024, 7:00pm
By Alex Biese
One expert explains how a break in TKI treatment could alleviate some toxicities, such as rash, for patients with non-small cell lung cancer.
August 9th 2024, 5:00pm
By Jane Biehl Ph.D.
Just like athletes in the Olympics, it's important for cancer survivors to keep track of everything they feel and to know their bodies well.
August 9th 2024, 3:00pm
From Patti Yasutake’s death from cancer to Olympic water polo player’s husband’s rare cancer diagnosis, here’s what’s happening in the oncology space this week.
August 9th 2024, 1:00pm
By Darlene Dobkowski, MA
An expert explained the importance of understanding different subtypes of metastatic breast cancer and available treatment options based on biomarker testing.
August 8th 2024, 9:00pm
By Pamela McColloch
Through colon cancer and liver cancer, faith is what brought me to peace and clarity during treatment and now survivorship.
August 8th 2024, 7:00pm
For patients with glioblastoma, collecting information about their disease and treatment options is important before providing informed consent.
August 8th 2024, 6:19pm
Join us for an Educated Patient® Webinar to explore the essential aspects of radiotherapy as a treatment for cancer, in addition to its various types and practical advice on managing side effects.
August 8th 2024, 5:00pm
By Karen Cohn
When I started experiencing symptoms of an infection, I was worried that my follicular lymphoma had returned.
August 8th 2024, 2:01pm
The cancer vaccine, mRNA-4157, garnered immune responses of 30 weeks among some patients with melanoma and lung cancer, study results showed.
August 8th 2024, 12:52pm
Lymphir, an immunotherapy, has been approved by the FDA to treat patients with relapsed or refractory cutaneous T-cell lymphoma.
August 7th 2024, 9:00pm
By Jordyn Sava
The National Comprehensive Cancer Network now recommends Rytelo for patients with myelodysplastic syndrome who require blood transfusions.
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC